De-Yan Liu
Overview
Explore the profile of De-Yan Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao X, Zhang J, Lu Y, Zhao Y, Liu D, Xiong M, et al.
Br J Haematol
. 2024 Apr;
204(6):2351-2364.
PMID: 38613241
CD7-targeted chimeric antigen receptor T-cell (CAR-T) therapy has shown promising initial complete remission (CR) rates in patients with refractory or relapsed (r/r) T-cell acute lymphoblastic leukaemia and lymphoblastic lymphoma (T-ALL/LBL)....
2.
Cao X, Zhang J, Zhao Y, Xiong M, Zhou J, Lu Y, et al.
Front Immunol
. 2023 Jul;
14:1191382.
PMID: 37469510
Background: Chimeric antigen receptor (CAR) T-cell therapy has demonstrated high initial complete remission (CR) rates in B-cell acute lymphoblastic leukemia (B-ALL) patients, including those who relapsed after transplant. However, the...
3.
Lu Y, Zhang J, Zhao Y, Xiong M, Sun R, Cao X, et al.
Front Immunol
. 2023 Jan;
13:1066748.
PMID: 36685540
Introduction: We aimed to evaluate prognostic factors of a second allogeneic stem cell transplantation (allo-HSCT2) among hematological malignancy patients who have relapsed after the first allo-HSCT(allo-HSCT1). Methods: We retrospectively analyzed...
4.
Lu Y, Xiong M, Sun R, Zhang J, Zhao Y, Wei Z, et al.
Leuk Lymphoma
. 2022 Sep;
63(14):3307-3316.
PMID: 36067518
We retrospectively analyzed the outcomes of 240 pediatric SAA patients who underwent unmanipulated alternative HSCT between September 2012 and November 2020 at our center. The incidence of GF (PGF + ...
5.
Zhao Y, Liu D, Sun R, Zhang J, Zhou J, Wei Z, et al.
Front Immunol
. 2021 May;
12:605766.
PMID: 34025637
Patients often undergo consolidation allogeneic hematopoietic stem cell transplantation (allo-HSCT) to maintain long-term remission following chimeric antigen receptor (CAR) T-cell therapy. Comparisons of safety and efficacy of allo-HSCT following complete...
6.
Lu Y, Xiong M, Sun R, Zhao Y, Zhang J, Cao X, et al.
Hematology
. 2021 Jan;
26(1):134-143.
PMID: 33491597
: The outcomes of alternative donor hematopoietic stem cell transplantation (HSCT) with unmanipulated grafts for Inherited bone marrow failure syndromes (IBMFS) are discouraging. Our study is to demonstrate that IBMFS...
7.
Lu Y, Zhao Y, Zhang J, Xiong M, Cao X, Liu D, et al.
Ann Hematol
. 2020 Nov;
100(6):1579-1591.
PMID: 33236196
There are a limited number of studies comparing outcomes of busulfan (BU)-based myeloablative hematopoietic stem cell transplantation using unmanipulated haploidentical donors (HIDs), HLA-matched unrelated donors (MUDs), and HLA-matched sibling related...
8.
Lu Y, Zhao Y, Zhang J, Xiong M, Cao X, Liu D, et al.
Ann Hematol
. 2020 Oct;
99(12):2911-2925.
PMID: 33000361
Prior studies have suggested that for leukemia patients with high-risk features, haplo-identical-hematopoietic stem cell transplantation (HID-HSCT) has a stronger anti-leukemia effect compared with HSCT using an identical sibling donor (ISD-HSCT)....
9.
Sun H, Wan Z, Liu D, Liao X, Ding W
Huan Jing Ke Xue
. 2020 Jul;
41(3):1474-1481.
PMID: 32608651
The North China Plain is an important grain production area in China. Due to the low content of soil organic carbon, increasing the application rate of nitrogen fertilizer would not...
10.
Lu Y, Sun R, Zhao Y, Xiong M, Cao X, Zhang J, et al.
Biol Blood Marrow Transplant
. 2018 May;
24(9):1881-1887.
PMID: 29772350
Salvage haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is considered in patients with severe aplastic anemia (SAA) if a matched unrelated donor (MUD) is unavailable. However, studies on haplo- and MUD...